During the past decade, Magyar Honvédség Egészségügyi Központ conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 55 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 47 clinical trials were completed. i.e. 117.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Magyar Honvédség Egészségügyi Központ" #1 sponsor was "Bayer" with 12 trials, followed by "Celgene" with 8 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Pfizer" with 7 trials sponsored and "Amgen" with 7 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Magyar Honvédség Egészségügyi Központ" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Canadian VIGOUR Centre" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Magyar Honvédség Egészségügyi Központ" are "Ulcerative Colitis" (11 trials), "Crohn's Disease" (7 trials), "Crohn Disease" (6 trials), "Acute Myocardial Infarction" (4 trials) and "Heart Failure" (4 trials). Many other conditions were trialed in "Magyar Honvédség Egészségügyi Központ" in a lesser frequency.

Most popular intervention types in "Magyar Honvédség Egészségügyi Központ" are "Drug" (93 trials), "Other" (25 trials), "Biological" (11 trials), "Device" (6 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "Guselkumab" (5 trials), "Ontamalimab" (4 trials), "Ozanimod" (4 trials) and "Abemaciclib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Magyar Honvédség Egészségügyi Központ" are 102 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Magyar Honvédség Egészségügyi Központ". undefined are not yet recruiting, 25 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 56 completed trials in Magyar Honvédség Egészségügyi Központ, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Magyar Honvédség Egészségügyi Központ, 4 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".

Magyar Honvédség Egészségügyi Központ has several departments that took part in Clinical trials: "Magyar Honvédség Egészségügyi Központ Onkológiai Osztály" - 12 trials, "Magyar Honvedseg Egeszsegugyi Kozpont,Reumatologiai osztaly" - 2 trials, "Magyar Honvédség Egészségügyi Központ, Neurológiai Osztály" - 2 trials, "Magyar Honvédség Egészségügyi Központ Kardiológiai Osztály" - 2 trials